GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (BOM:533543) » Definitions » Long-Term Debt

Brooks Laboratories (BOM:533543) Long-Term Debt : ₹0.0 Mil (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories Long-Term Debt?

Brooks Laboratories's Long-Term Debt for the quarter that ended in Dec. 2024 was ₹0.0 Mil.

Brooks Laboratories's quarterly Long-Term Debt increased from Jun. 2024 (₹0.0 Mil) to Sep. 2024 (₹1.5 Mil) but then declined from Sep. 2024 (₹1.5 Mil) to Dec. 2024 (₹0.0 Mil).

Brooks Laboratories's annual Long-Term Debt declined from Mar. 2022 (₹92.9 Mil) to Mar. 2023 (₹0.0 Mil) but then stayed the same from Mar. 2023 (₹0.0 Mil) to Mar. 2024 (₹0.0 Mil).


Brooks Laboratories Long-Term Debt Historical Data

The historical data trend for Brooks Laboratories's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brooks Laboratories Long-Term Debt Chart

Brooks Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 112.83 144.29 92.90 - -

Brooks Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1.46 -

Brooks Laboratories  (BOM:533543) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Brooks Laboratories Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Brooks Laboratories Business Description

Traded in Other Exchanges
Address
Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093
Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. The company operates under one segment: Pharmaceutical products including ingredients and intermediaries. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories Headlines

No Headlines